tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
KNSA
Kiniksa Pharmaceuticals
RESEARCH TOOLSreports

Kiniksa Pharmaceuticals (KNSA) Income Statement

Compare
553 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Kiniksa Pharmaceuticals's total revenue was $202.13M, an increase of 64.95% from the same quarter last year. In Q4, Kiniksa Pharmaceuticals's net income was $14.20M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 677.56M$ 423.24M$ 270.26M$ 220.18M$ 38.54M
Gross Profit
$ 370.15M$ 362.33M$ 213.74M$ 197.28M$ 29.44M
Operating Expenses
$ 292.93M$ 407.94M$ 238.93M$ 187.51M$ 186.08M
Depreciation and Amortization
$ 1.55M$ 1.70M$ 2.34M$ 2.40M$ 2.35M
EBITDA
$ 90.42M$ -43.92M$ -22.86M$ 12.18M$ -154.28M
Operating Income
$ 77.22M$ -45.62M$ -25.20M$ 9.77M$ -156.64M
Other Income/Expenses
$ 11.65M$ 9.46M$ 8.54M$ 1.25M$ 97.00K
Pretax Income
$ 88.87M$ -36.15M$ -16.65M$ 11.03M$ -156.54M
Net Income
$ 59.01M$ -43.19M$ 14.08M$ 183.36M$ -157.92M
Per Share Metrics
Basic EPS
$ 0.80$ -0.60$ 0.20$ 2.64$ -2.30
Diluted EPS
$ 0.75$ -0.60$ 0.20$ 2.60$ -2.30
Weighted Average Shares Outstanding
 74.20M 71.42M 70.06M 69.38M 68.58M
Weighted Average Shares Outstanding (Diluted)
 78.98M 71.42M 71.92M 70.42M 68.58M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History